DrugPatentWatch Database Preview

B Braun Company Profile

Email this page to a colleague

« Back to Dashboard

What is the competitive landscape for B BRAUN, and what generic alternatives to B BRAUN drugs are available?

B BRAUN has one hundred and sixteen approved drugs.

There are two US patents protecting B BRAUN drugs.

There are twenty-six patent family members on B BRAUN drugs in twenty-six countries and two hundred and eighteen supplementary protection certificates in sixteen countries.

Summary for B Braun

International Patents:	26
US Patents:	2
Tradenames:	225
Ingredients:	62
NDAs:	116

Drugs and US Patents for B Braun

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
B Braun	HEPARIN SODIUM 1,000 UNITS IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER	heparin sodium	INJECTABLE;INJECTION	019953-001	Jul 20, 1992	AP	RX	Yes	Yes
B Braun	POTASSIUM CHLORIDE 0.22% IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER	potassium chloride; sodium chloride	INJECTABLE;INJECTION	019708-005	Sep 29, 1989		DISCN	No	No
B Braun	ISOLYTE E IN DEXTROSE 5% IN PLASTIC CONTAINER	calcium chloride; dextrose; magnesium chloride; potassium chloride; sodium acetate; sodium chloride; sodium citrate	INJECTABLE;INJECTION	019867-001	Dec 20, 1993		DISCN	No	No
B Braun	DIALYTE CONCENTRATE W/ DEXTROSE 30% IN PLASTIC CONTAINER	calcium chloride; dextrose; magnesium chloride; sodium acetate; sodium chloride	SOLUTION;INTRAPERITONEAL	018807-001	Aug 26, 1983		DISCN	No	No
B Braun	CEFOXITIN AND DEXTROSE IN DUPLEX CONTAINER	cefoxitin sodium	INJECTABLE;INJECTION	065214-001	Mar 10, 2006	AP	RX	Yes	Yes
B Braun	LIDOCAINE HYDROCHLORIDE 0.4% AND DEXTROSE 5% IN PLASTIC CONTAINER	lidocaine hydrochloride	INJECTABLE;INJECTION	018967-002	Mar 30, 1984		DISCN	No	No
B Braun	DOPAMINE HYDROCHLORIDE AND DEXTROSE 5% IN PLASTIC CONTAINER	dopamine hydrochloride	INJECTABLE;INJECTION	019099-001	Oct 15, 1986		RX	Yes	Yes

Expired US Patents for B Braun

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
B Braun	HEPATAMINE 8%	amino acids	INJECTABLE;INJECTION	018676-001	Aug 3, 1982	3,950,529
B Braun	UCEPHAN	sodium benzoate; sodium phenylacetate	SOLUTION;ORAL	019530-001	Dec 23, 1987	4,284,647

International Patents for B Braun Drugs

Country	Patent Number	Estimated Expiration
Philippines	12015501313
Poland	1931304
Croatia	P20131221
Russian Federation	2015128024
Brazil	PI0615702
Argentina	099443
Serbia	53077

Supplementary Protection Certificates for B Braun Drugs

Patent Number	Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
1948158	1690020-1	Sweden		PRODUCT NAME: SACUBITRIL AND VALSARTAN, AS SACUBITRIL VALSARTAN SODIUM SALT COMPLEX, I.E. TRISODIUM 3-((1S,3R)-1-BIPHENYL-4-YLMETHYL-3- ETHOXYCARBONYL-1-BUTYLCARBAMOYL)PROPIONATE-(S)-3-METHYL-2- (PENTANOYL2-(TETRAZOL-5-YLATE)BIPHENYL-4- YLMETHYLAMINO)BUTYRATE HEMIPENTAHYDRATE; REG. NO/DATE: EU/1/15/1058 20151123
0720599	300689	Netherlands		PRODUCT NAME: EZETIMIBE, DESGEWENST IN DE VORM VAN EEN FARMACEUTISCH AANVAARDBAAR ZOUT, EN ATORVASTATINE, DESGEWENST IN DE VORM VAN EEN FARMACEUTISCH AANVAARDBAAR ZOUT, IN HET BIJZONDER ATORVASTATINE CALCIUM TRIHYDRATE; NATIONAL REGISTRATION NO/DATE: RVG114373-114376 20141027; FIRST REGISTRATION: FR 2014091200122 20140912
0392059	0290025-6	Sweden		PRODUCT NAME: MEMANTIN, 1-AMINO-3,5-DIMETYLADAMANTAN; REGISTRATION NO/DATE: EU/1/02/219/001 20020515
2365988	LUC00061	Luxembourg		PRODUCT NAME: PATIROMER SORBITEX CALCIUM ET TOUS LES SELS ET DERIVES DE CELUI-CI; AUTHORISATION NUMBER AND DATE: EU/1/17/1179 20170721
2203431	92666	Luxembourg		PRODUCT NAME: DASABUVIR OU UN SEL QUI EN DERIVE, Y COMPRIS DASABUVIR SODIUMMONOHYDRATE. FIRST REGISTRATION: 20150119
2395002	300812	Netherlands		PRODUCT NAME: 3-(6-((1-(2,2-DIFLUOR-1,3-BENZODIOXOL-5-YL)CYCLOPROPAANCARBONYL)AMINO)-3-METHYLPYRIDIN-2-YL)BENZOEZUUR, OF EEN FARMACEUTISCH AANVAARDBAAR ZOUT DAARVAN; REGISTRATION NO/DATE: EU/1/15/1059 20151124
0863901	PA2004008	Lithuania		PRODUCT NAME: ERTAPENEMUM ([4R,5S,6S]-3-[(3S,5S)-5-[(3-KARBOKSIFENIL) AMINO]KARBONIL]-3-PIROLIDINIL]TIO]-6-[(1R)-1HIDROKSIETIL]-4-METIL-7-OKSO-1-AZABICIKLO-[3.2.0]HEPT-2-EN-2-KARBOKSIRUGSTIS; REGISTRATION NO/DATE: 03/8043/3 20030328

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

• B Braun
• B Braun Medical Inc